Open tender · Germany · Contract notice
Open house Arzneimittelrabattverträge Natalizumab in der Darreichungsform Konz.z.Herst.e.Inf.-Lsg. , ATC L04AG03
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open house Arzneimittelrabattverträge Natalizumab in der Darreichungsform Konz.z.Herst.e.Inf.-Lsg. , ATC L04AG03”. Bids close on 3 October 2027.
The work
Non-exclusive discount agreements for the active substance Natalizumab in the dosage form Konzentrat zur Herstellung von Infusionslösungen, ATC L04AG03.
- Contracts are identical and non-negotiable
- A contract can be terminated with one month's notice at the end of a month
- The contract is automatically superseded by a nationally or regionally concluded discount agreement for the same substance
Key facts
- Contract period
- From 01.12.2025 to 30.11.2027, with a possible contract conclusion until 03.10.2027.
- Evaluation
- This is an open-house model, not a competitive tender. All interested parties meeting the eligibility criteria are offered the same contract.
What it takes to qualify
Worth a closer look
- The tender document is in German and appears to be for a German entity (AOK Bayern). It is not clear if this is an Indian government tender or if Indian-specific compliance requirements (like GST, PAN, etc.) apply.
- The document mentions a 'Vergabestelle SGB V' and a portal 'www.dtvp.de', which are German procurement entities and portals.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- ausgefüllte und unterzeichnete Eigenerklärung zur Zuverlässigkeitmust be signed, representation authority must be evident from trade register extract or a power of attorney must be submitted
- ausgefüllter und unterzeichneter Vertragmust be signed, representation authority must be evident from trade register extract or a power of attorney must be submitted
- ausgefüllte und unterzeichnete Anlage "Festlegung der vertragsgegenständlichen Arzneimittel"must be signed